IPO

New Business

In Hong Kong vs Trump 2.0, global CEOs see new hopes, old threats

China envisions Hong Kong’s capital markets as a beacon of prosperity, having lifted the city out of social chaos in…

Read More »
New Business

Uber said to eye US$10 million stake in IPO of China’s Pony AI amid self-driving boom

Uber Technologies plans to invest in Pony AI’s US initial public offering (IPO), which is expected to be priced next…

Read More »
New Business

Opinion | Quality should come before quantity for Hong Kong’s IPOs

Hong Kong has long stood as a beacon of financial prowess, with its stock exchange often leading the world in…

Read More »
New Business

Hong Kong listings remain muted as cautious issuers play wait-and-see, law firms say

Weak market sentiment and general economic uncertainty in mainland China continues to breed caution in Hong Kong’s capital market, causing…

Read More »
Tech

Chinese autonomous-driving firm WeRide seeks up to US$440 million in US IPO, placement

A group of investors agreed to buy US$320.5 million worth of ordinary shares via private placements, the filing shows. Alliance…

Read More »
New Business

Hong Kong IPO: China’s Black Sesame raises US$133 million in tough market conditions

Mainland Chinese car chip designer Black Sesame International Holding has become Hong Kong’s fifth-largest listing of the year after pricing…

Read More »
Tech

Chinese biotech sector is blowing hot as M&A and IPO deals surge amid Covid-19 pandemic

China’s biotechnology merger and acquisition (M&A) transactions have almost doubled this year, with interest perking up among investors amid a…

Read More »
Tech

Yifan Pharma’s unit, eyeing US$5.5 billion post-chemotherapy treatment market dominated by Amgen, considers IPO in 2021

Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…

Read More »
Tech

Mergers afoot for China’s biotechnology industry as suppliers become attractive targets for Big Pharma

China’s fragmented outsourced drug discovery services market will see further consolidation as companies seek to grab market share amid a…

Read More »
Tech

Chinese wealth management unicorn Lufax on path to biggest US listing by Chinese issuer this year, targets US$2.4 billion IPO

Chinese wealth management unicorn Lufax Holding is selling American depositary shares (ADSs) in an initial public offering (IPO) on the…

Read More »
Back to top button